Back to top
more

If you wish to go to ZacksFunds.com, click OK. If you do not, click Cancel.

Rydex Srs Trust Biotechnology Fd: (MF: RYOIX)

(MF) As of Jul 2, 2015 06:06 PM ET

 Add to portfolio

$100.40 USD

-0.21 (-0.21%)

Zacks MF Rank : 4 - Sell [?]       4  

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

Latest Performance as of May 31, 2015

Total Return %* Percentile Rank Objective
YTD 21.47 6
3 months 8.38 4
6 months 21.44 15
1 Year 54.95 12
3 Year 41.15 11
5 Year 34.54 8
10 Year 18.64 9

* Annual for three years and beyond.

Zacks Premium Research for RYOIX

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

Zacks MF Rank [?] Sell 4
MF Research Report

Mutual Funds Research & Tools

Search Similar Mutual Funds

Research similar Mutual Funds with higher ranks and performance ratings.

Mutual Funds Comparison View (minimum of 2)

Mutual Funds Screener

Narrow down the universe of 18,000+ funds we rank with our robust, yet easy-to-use mutual fund screeners. Select from up to 50 different data points to find the mutual funds that best Screen meet your unique criteria.

Portfolio Statistics

%Unrealized Gain YTD 45.22
% Yield 0.00
% SEC Yield NA
Net Assets (Mil $) 5/31/2015 309.39
%Turnover 5/31/2015 119.00

Risk

3 Year 5 Year 10 Year
Beta 0.97 0.91 0.86
Alpha 20.88 18.62 11.92
R Squared 0.16 0.32 0.37
Std. Dev. 20.46 19.95 20.86
Sharpe 2.14 1.85 1.00

Sector / Country Weightings

As of 5/31/2015 % of Portfolio
Health 64.76
Services 20.92
Other 8.06
Technology 5.08
Industrial Cyclical 0.73
Retail Trade 0.45

Portfolio Holdings

Top Equity Holdings
(As of 3/31/2015)
% of Portfolio Value (Mil$)
GILEAD SCIENCES INC 6.78 46.88
AMGEN INC 6.08 42.06
BIOGEN INC 5.70 39.44
CELGENE CORP 5.32 36.80
REGENERON PHARMACEUTICALS 3.54 24.52
ALEXION PHARMACEUTICALS I 3.32 22.98
VERTEX PHARMACEUTICALS IN 2.88 19.90
ILLUMINA INC 2.82 19.52
BIOMARIN PHARMACEUTICAL 2.56 17.71

Stock Holding % of Net Assets

As Of 3/31/2015
Total Issues 78
Avg. P/E 34.20
Avg. P/Book 5.93
Avg. EPS Growth 16.41
Avg. Market Value (Mil $) 33,214

Allocation

% of Portfolio
Large Growth 18.78
Large Value 0.00
Small Growth 29.62
Small Value 0.00
Foreign Stock 0.00
Emerging Market 0.00
Precious Metal 0.00
Intermediate Bond 0.00
Foreign Bond 0.00
High Yield Bond 0.00